Skip to main content
Article thumbnail
Location of Repository

Local and global modes of drug action in biochemical networks

By Jean-Marc Schwartz and Jose C Nacher
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2670818
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2006). AL: Global mapping of pharmacological space.
    2. (2008). AL: The implications of human metabolic network topology for disease comorbidity. Proc Natl Acad Sci USA
    3. (2007). AMENDA and FRENDA: the enzyme information system in 2007. Nucleic Acids Res
    4. (1979). Aspirin-like drugs interfere with arachidonate metabolism by inhibition of the 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid peroxidase activity of the lipoxygenase pathway. Proc Natl Acad Sci USA
    5. (2005). Cancer drug discovery through collaboration. Nat Rev Drug Discov
    6. (2006). Cancer: a systems biology disease. Biosystems
    7. (2005). Cho YB: Effects of SKI306X on arachidonate metabolism and other inflammatory mediators. Biol Pharm Bull
    8. (2007). Drug-target network. Nat Biotechnol
    9. (2008). Drug-therapy networks and the prediction of novel drug targets.
    10. (2007). DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res
    11. (2008). Ebenhöh O: Biosynthetic potentials of metabolites and their hierarchical organization. PLoS Comput Biol
    12. (2007). Ebenhöh O: MetaPath Online: a web server implementation of the network expansion algorithm. Nucleic Acids Res
    13. (2004). EC: Systems biology in drug discovery. Nat Biotechnol
    14. (2005). Expanding metabolic networks: scopes of compounds, robustness, and evolution.
    15. (2008). From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage. Curr Med Chem
    16. (2003). HG: The price of innovation: new estimates of drug development costs.
    17. (2006). Hierarchy of metabolic compounds based on their synthesising capacity. Syst Biol
    18. (2008). JM: A global view of drug therapy interactions.
    19. (2008). KEGG for linking genomes to life and the environment. Nucleic Acids Res
    20. (2007). Network analysis of FDA approved drugs and their targets.
    21. (1983). Network structure and minimum degree. Social Networks
    22. (2005). Pharmaceuticals A new grammar for drug discovery. Nature
    23. (2005). Pongor S: The efficiency of multi-target drugs: the network approach might help drug design. Trends Pharmacol Sci
    24. (2006). Segrè D: The effect of oxygen on biochemical networks and the evolution of complex life. Science
    25. (2004). Structural analysis of expanding metabolic networks. Genome Inform
    26. (2006). Systems biology, metabolic modelling and metabolomics in drug discovery and development. Drug Discov Today
    27. (2005). Target-based drug discovery: is something wrong? Drug Discov Today
    28. (2003). Zaversnik M: An O(m) algorithm for cores decomposition of networks.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.